Cardiovascular Disease Clinical Trial
Official title:
Physical Activity for Campus Employees
The aim of this pilot study is to evaluate the effects of a worksite wellness program on physical activity and cardiovascular disease risk factors among university employees. The investigators hypothesize that the proposed worksite wellness program will be effective for increasing daily physical activity and improving one or more cardiovascular disease risk factors among university employees.
Cardiovascular disease (CVD) persists as the leading cause of mortality in the United States
and accounts for 17 percent of the nation's overall health expenditures. Although the
mortality rate of CVD has declined in recent years, the burden of disease remains high.
Currently, 1 in 3 Americans has some form of CVD. Additionally, according to a recent policy
statement published by the American Heart Association (AHA), 40% of the population is
projected to have some form of CVD by 2030. Furthermore, the AHA has projected that the cost
to treat CVD will triple by 2030. The prevalence and rising financial burden of CVD
demonstrate the urgency for effective implementation of disease prevention strategies.
Evidence suggesting the majority of CVD is preventable through modifiable risk factor
management continues to grow. Nonetheless, difficulty controlling modifiable risk factors
remains an issue for many Americans. The magnitude of this challenge is supported by a study
revealing that 78% of adults are candidates for at least one CVD prevention activity.
Although national organizations have published a variety of disease prevention
recommendations, widespread implementation of and adherence to preventative programs remain
problematic. Consequently, a large proportion of the population is not receiving or
participating in prevention strategies from which they may benefit. The full potential of
reducing the nation's CVD burden cannot be achieved unless interventions are implemented on
a larger scale, with reduced costs, and with increased initial and continued participation.
With approximately 130 million Americans currently employed, workplaces provide ideal
environments for implementation of sizable, cost-effective CVD prevention programs. However,
successful wellness programming remains a laborious, resource intensive challenge for
employers. In 2004, a National Worksite Health Promotion Survey disclosed that less than 7%
of U.S. employers offered worksite wellness programs. Furthermore, an estimated 25-30% of
companies' annual medical costs are spent on employees with CVD risk factors.
In the proposed study, a worksite wellness program that includes health assessments,
personal health reports, and pedometer-based tracking of physical activity will be offered
to university employees. Participants will not be randomized to an intervention or control
group. Rather, program components will be available to all enrolled participants, and each
individual may choose whether to wear a pedometer, track their step counts, attend wellness
sessions, and/or complete the health assessments. There is no prescribed intervention.
Wellness sessions include educational information on lifestyle behaviors to promote
cardiometabolic health.
;
Observational Model: Cohort, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02122198 -
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
|
N/A | |
Completed |
NCT02502812 -
Bioequivalence Study of Clopidogrel 75 mg in Two Tablet Formulations Relative to Reference Tablet in Healthy Subjects
|
Phase 1 | |
Recruiting |
NCT04216342 -
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Fx-5A in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT03654313 -
Single and Multiple Ascending Doses of MEDI6570 in Subjects With Type 2 Diabetes Mellitus
|
Phase 1 | |
Completed |
NCT03646656 -
Heart Health Buddies: Peer Support to Decrease CVD Risk
|
N/A | |
Completed |
NCT02081066 -
Identification of CETP as a Marker of Atherosclerosis
|
N/A | |
Completed |
NCT02147626 -
Heart Health 4 Moms Trial to Reduce CVD Risk After Preeclampsia
|
N/A | |
Not yet recruiting |
NCT06405880 -
Pharmacist Case Finding and Intervention for Vascular Prevention Trial
|
N/A | |
Recruiting |
NCT03095261 -
Incentives in Cardiac Rehabilitation
|
N/A | |
Completed |
NCT02589769 -
Effects of Reduction in Saturated Fat on Cholesterol and Lipoproteins in Lean and Obese Persons
|
N/A | |
Completed |
NCT02711878 -
Healing Hearts and Mending Minds in Older Adults Living With HIV
|
N/A | |
Completed |
NCT02998918 -
Effects of Short-term Curcumin and Multi-polyphenol Supplementation on the Anti-inflammatory Properties of HDL
|
N/A | |
Not yet recruiting |
NCT02578355 -
National Plaque Registry and Database
|
N/A | |
Completed |
NCT02868710 -
Individual Variability to Aerobic Exercise Training
|
N/A | |
Recruiting |
NCT02885792 -
Coronary Artery Disease in Patients Suffering From Schizophrenia
|
N/A | |
Completed |
NCT02272946 -
Effect of IL--1β Inhibition on Inflammation and Cardiovascular Risk
|
Phase 2 | |
Completed |
NCT02640859 -
Investigation of Metabolic Risk in Korean Adults
|
||
Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
Completed |
NCT02657382 -
Mental Stress Ischemia: Biofeedback Study
|
N/A | |
Recruiting |
NCT02265250 -
Pilot Study-Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment
|